Notes on US HIV Market from GILD CC Total US patients on therapy: 530K Proportion of total on Viread in some form: 68% (up from 64% one year ago) Proportion of total on Truvada in some form: 31% Proportion of total on Atripla: 28% Note: the above figures are for all treatment settings, while the pie chart in <a href='read_msg.asp?message_id=26915314'>#msg-26915314</a> is for the first-line setting only.